Wolfe Research analyst Sam Margolin downgrades ConocoPhillips (NYSE:COP) from Outperform to Peer Perform.
Analyst Ratings for Cytokinetics
Cytokinetics (NASDAQ:CYTK) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…